Ipamorelin
10mg
⚠️ Not for human consumption. Research purposes only.
Description
Ipamorelin is a selective growth hormone secretagogue (GHS) pentapeptide that binds to the ghrelin/GHS receptor. It has been investigated in preclinical and clinical studies for its selective stimulation of growth hormone release without significant effects on cortisol or prolactin levels, making it a subject of interest in endocrine signaling research.
Key Areas of Study
- Selective GH secretagogue research
- ghrelin receptor binding studies
- endocrine signaling pathway analysis
- somatotroph cell activation modeling
Mechanisms Being Evaluated
Ipamorelin mimics ghrelin and binds to the GHS-R1a receptor on pituitary somatotroph cells, stimulating growth hormone release in a dose-dependent manner. Studies have noted its selectivity, with minimal impact on ACTH, cortisol, or prolactin secretion compared to other GHS compounds.
Commonly Researched Uses
Growth hormone secretagogue receptor research, selective endocrine modulation studies, pituitary signaling pathway analysis, GHS compound comparison studies
Recent Studies and Trials
The following peer-reviewed studies and clinical trials have investigated the properties and applications of this peptide:
Growth Hormone Secretagogue Effects
Published: 1998
Ipamorelin in Postoperative Ileus
Published: 2008
Safety Profile in Clinical Applications
Published: 2019
Note: These studies are provided for informational and research purposes only. This product is not intended for human consumption.